Table 3 Main findings of HIV patients in Medellín, Colombia from August 2014 to July 2015
From: Hospitalization causes and outcomes in HIV patients in the late antiretroviral era in Colombia
Variable | Patients who died (n = 30) n (%) | Patients who survived (n = 521) n (%) |
|---|---|---|
Age | 41.5 | 39.3 |
Male | 25/30 (83.3) | 393/521 (75.4) |
Diagnosis during the index admission | 9/30 (30.0) | 112/521 (21.5) |
Previous HIV diagnosisa | 21/30 (70.0) | 409/521 (78.5) |
Diagnosis 1–12 months | 6/30 (20.0) | 117/521 (22.5) |
Diagnosis > 12 months | 15/30 (50.0) | 292/521 (56.0) |
On antiretroviral therapy at admissionb | 11/21 (52.4) | 262/409 (64.2) |
Adherencec | 5/18 (27.7) | 194/354 (54.8) |
CD4 T-cells count < 200 cells/mLd | 28/29 (96.6) | 352/521 (67.4) |
AIDS-defining illness on admission | 24/30 (80.0) | 277/521 (53.2) |
Patients with newly diagnosed TB | 7/30 (23.3) | 121/521 (23.2) |
AIDS defining illness no TB | 17/30 (56.6) | 156/521 (29.9) |
Two or more OIs | 11/30 (36.6) | 96/521 (18.4) |
Non-AIDS-defining illness but related to HIV | 2/30 (6.6) | 33/521 (6.3) |